A. Gruessner

636 total citations
22 papers, 430 citations indexed

About

A. Gruessner is a scholar working on Surgery, Transplantation and Obstetrics and Gynecology. According to data from OpenAlex, A. Gruessner has authored 22 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 16 papers in Transplantation and 2 papers in Obstetrics and Gynecology. Recurrent topics in A. Gruessner's work include Renal Transplantation Outcomes and Treatments (16 papers), Organ Transplantation Techniques and Outcomes (14 papers) and Transplantation: Methods and Outcomes (5 papers). A. Gruessner is often cited by papers focused on Renal Transplantation Outcomes and Treatments (16 papers), Organ Transplantation Techniques and Outcomes (14 papers) and Transplantation: Methods and Outcomes (5 papers). A. Gruessner collaborates with scholars based in United States and Jordan. A. Gruessner's co-authors include David E.R. Sutherland, Rainer W.G. Gruessner, Mary Beth Drangstveit, Raja Kandaswamy, Abhinav Humar, E. Benedetti, Rainer Gruessner, John S. Najarian, J. Philip Boudreaux and Robert J. Stratta and has published in prestigious journals such as Transplantation, American Journal of Transplantation and Surgery.

In The Last Decade

A. Gruessner

22 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gruessner United States 10 366 273 87 42 32 22 430
Hakala Tr United States 10 214 0.6× 229 0.8× 82 0.9× 28 0.7× 16 0.5× 21 388
Albin Gritsch United States 6 230 0.6× 204 0.7× 116 1.3× 12 0.3× 6 0.2× 9 376
Pirsch Jd United States 11 304 0.8× 113 0.4× 92 1.1× 14 0.3× 18 0.6× 29 373
G. Florack United States 10 416 1.1× 95 0.3× 48 0.6× 43 1.0× 32 1.0× 31 488
F. Di Giambattista France 7 208 0.6× 302 1.1× 38 0.4× 7 0.2× 22 0.7× 13 376
M Hourmant France 9 93 0.3× 125 0.5× 41 0.5× 28 0.7× 5 0.2× 22 294
Sabrina Louie United States 6 120 0.3× 197 0.7× 35 0.4× 10 0.2× 13 0.4× 7 288
John R. Ackermann United States 11 133 0.4× 132 0.5× 83 1.0× 10 0.2× 5 0.2× 14 304
Pedro Nunes Portugal 13 159 0.4× 174 0.6× 174 2.0× 34 0.8× 3 0.1× 38 372
TE Starzl United States 7 116 0.3× 112 0.4× 24 0.3× 15 0.4× 4 0.1× 20 276

Countries citing papers authored by A. Gruessner

Since Specialization
Citations

This map shows the geographic impact of A. Gruessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gruessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gruessner more than expected).

Fields of papers citing papers by A. Gruessner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gruessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gruessner. The network helps show where A. Gruessner may publish in the future.

Co-authorship network of co-authors of A. Gruessner

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gruessner. A scholar is included among the top collaborators of A. Gruessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gruessner. A. Gruessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misawa, Ryosuke, et al.. (2019). Adjuvant chemotherapy for pancreatic neuroendocrine tumor: is there a real benefit?. HPB. 21. S179–S180. 1 indexed citations
2.
Laftavi, M.R., A. Gruessner, & Rainer W.G. Gruessner. (2017). Surgery of pancreas transplantation. Current Opinion in Organ Transplantation. 22(4). 389–397. 20 indexed citations
3.
Gruessner, A., Nisreen Abu Shahin, Yi Zhou, et al.. (2014). Flutamide and Biomarkers in Women at High Risk for Ovarian Cancer: Preclinical and Clinical Evidence. Cancer Prevention Research. 7(9). 896–905. 13 indexed citations
4.
Gruessner, A., et al.. (2014). Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.. PubMed. 4(1). 61–72. 13 indexed citations
5.
Rizzari, Michael, A. Gruessner, Robert R. Redfield, et al.. (2014). Pancreas Retransplantation: A 10-Year Report of International Pancreas Transplant Registry Outcomes.. Transplantation. 98. 214–214. 2 indexed citations
6.
Humar, Abhinav, et al.. (2004). The Impact of Donor Obesity on Outcomes after Cadaver Pancreas Transplants. American Journal of Transplantation. 4(4). 605–610. 66 indexed citations
7.
Sutherland, D. E., Abhinav Humar, Raja Kandaswamy, et al.. (2001). Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetic recipients. Transplantation Proceedings. 33(1-2). 1656–1658. 9 indexed citations
8.
Humar, Abhinav, et al.. (2000). Prolonged preservation increases surgical complications after pancreas transplants. Surgery. 127(5). 545–551. 45 indexed citations
9.
Humar, A., et al.. (2000). Surgical risks and outcome of pancreas retransplants. Surgery. 127(6). 634–640. 21 indexed citations
10.
Humar, Abhinav, James V. Harmon, A. Gruessner, et al.. (1998). SURGICAL COMPLICATIONS REQUIRING EARLY RELAPAROTOMY AFTER PANCREAS (Pa) TRANSPLANTATION (Tx): COMPARISON OF THE FK AND CsA ERA. Transplantation. 66(8). S23–S23. 2 indexed citations
11.
Kandaswamy, Raja, A. Humar, A. Gruessner, et al.. (1998). VASCULAR GRAFT THROMBOSIS AFTER PANCREAS TRANSPLANTATION: COMPARISON OF THE FK AND CsA ERA. Transplantation. 66(8). S36–S36. 2 indexed citations
12.
Gruessner, Rainer, George W. Burke, Robert J. Stratta, et al.. (1996). A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1. Transplantation. 61(2). 261–273. 109 indexed citations
13.
Pirenne, Jacques, A. Gruessner, E. Benedetti, et al.. (1996). Addition of the colon to small bowel grafts causes lethal graft-versus-host disease in FK 506-treated pigs.. PubMed. 28(2). 886–7. 2 indexed citations
14.
Sutherland, David E.R. & A. Gruessner. (1995). Long-term function (> 5 years) of pancreas grafts from the International Pancreas Transplant Registry database.. PubMed. 27(6). 2977–80. 14 indexed citations
15.
Gruessner, Rainer W.G., Carlos G. Fasola, E. Benedetti, et al.. (1995). Laparoscopic drainage of lymphoceles after kidney transplantation: Indications and limitations. Surgery. 117(3). 288–295. 59 indexed citations
16.
Moudry-Munns, K., A. Gruessner, & David E.R. Sutherland. (1994). Analysis of United States pancreas transplant registry data. 4(1). 18–22. 3 indexed citations
17.
Sutherland, David E.R., K. Moudry-Munns, & A. Gruessner. (1994). Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.. PubMed. 26(5). 2752–5. 9 indexed citations
18.
Gruessner, Rainer, Raouf E. Nakhleh, Jeffrey L. Platt, et al.. (1993). Rejection In Single Versus Combined Pancreas And Kidney Transplantation In Pigs. Transplantation. 56(5). 1053–1061. 25 indexed citations
19.
Stevens, R. Brian, Paola Fioretto, Adam Lokeh, et al.. (1993). Correlation of preoperative renal function and identification of risk factors for eventual native renal failure in cyclosporine-treated nonuremic diabetic recipient of pancreas transplants alone.. PubMed. 25(1 Pt 2). 1291–2. 7 indexed citations
20.
Sutherland, David E.R., A. Gruessner, K. Moudry-Munns, & Michael Cecka. (1993). Tabulation of cases from the International Pancreas Transplant Registry and analysis of United Network for Organ Sharing United States Pancreas Transplant Registry data according to multiple variables.. PubMed. 25(1 Pt 2). 1707–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026